NLRP3 and cryopyrin-associated periodic syndrome: Eight patients (24%) were clinically diagnosed as Cryopyrin-associated periodic syndromes (CAPS) with low-penetrance NLRP3 variants (V198M, Q703K) showing overlap characteristics for the mild to moderate CAPS phenotype.